TestGorilla Launches New AI Readiness and AI Fluency Assessments to Help Companies Hire for the Skills That Matter Now
3.3.2026 11:34:00 CET | Business Wire | Press Release
TestGorilla, the skills-based hiring platform trusted by thousands of organisations worldwide, today announced a suite of new assessments and simulation tests purpose-built to help talent acquisition teams evaluate AI readiness and AI fluency off the back of the company’s flagship event: Hire for the AI Era.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260303398545/en/
Use validated assessments and structured AI video interviews through the TestGorilla platform to measure different aspects of AI fluency across technical and non-technical roles. Inside the platform, tools are clearly labeled with AI fluency making it easy to find and build an assessment.
The launch coincides with a crucial shift in the hiring landscape. TestGorilla co-founder and CEO Wouter Durville shared data at the event highlighting this change: 70% of companies now report integrating AI into their core workforces, and 71% of leaders prioritize AI skills over years of experience in recruitment. Although 95% of companies cite AI literacy as an active hiring factor, most existing hiring processes remain rooted in a pre-AI reality. As Durville noted, “AI has permanently altered the signal in hiring.”
The Science Behind the Assessments: TestGorilla’s AI Fluency Framework
All new products are underpinned by TestGorilla’s proprietary five-pillar AI Fluency Framework, developed by the company’s in-house team of organisational scientists and psychologists. The framework defines AI fluency not as a single skill, but as five measurable dimensions that together determine whether a candidate can operate effectively and responsibly in an AI-augmented workplace:
- AI Literacy: The foundational ability to work with AI tools effectively.
- Learning and Digital Agility: The capacity to learn, unlearn, and adapt to new tools at speed as technology evolves.
- Systems Thinking and Problem Solving: The ability to understand how AI fits into a broader workflow, breaking problems into components, selecting the right tool, and knowing where AI should and shouldn’t operate.
- Ethics and Responsible Use: The judgment to use AI transparently and responsibly — knowing when to place the human in the loop and how to act with accountability.
- Human-AI Collaboration: The ability to work fluidly alongside AI and knowing when to lean on the machine and when to take the wheel.
“AI fluency isn’t just prompt engineering,” said Durville. “It’s all five aspects working together and the good news is you can measure all of them.”
AI Video Interviews and Simulation Tests
TestGorilla has launched two new AI video interview assessments built directly on the framework:
- Learning Agility: Evaluates a candidate’s ability to adapt, reflect on feedback, and learn dynamically. The essentials for any role where tools and expectations shift fast.
- AI Readiness: Evaluates a candidate’s ability to responsibly use, adapt to, and collaborate with AI tools in the workplace.
In addition, over 70 existing AI video interviews have been updated to embed one to two AI fluency questions directly into role-specific evaluation. An industry first where role-level AI readiness is assessed at scale.
Five new simulation tests are also now available, using the same conversational AI technology as TestGorilla’s video interviews: Algorithmic Reasoning, B2B Account Management, Conflict Handling for Customer Success, Soft Skills for Customer Success, and Tech Collaboration.
“The resume was built for a pre-AI world,” said Durville. “Updating your hiring stack isn’t optional anymore. It’s how you restore confidence in your signal and make great hires.”
All new features are available now in the TestGorilla platform.
About TestGorilla
TestGorilla is the global talent discovery platform that helps employers source and hire based on proven skills. With a pool of 2m+ skills-tested candidates, 350+ science-backed assessments, and AI-powered sourcing and evaluation, we give organizations a faster, fairer, and smarter way to hire.
Since launching in 2020, more than 60,000 organizations have used TestGorilla, and the platform now assesses 7 million candidates annually. Our vision is to put one billion people into their dream roles through skills-based hiring.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260303398545/en/
Contacts
Media Contact
Estee Chaikin
Press Office, TestGorilla
press@testgorilla.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom